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Abstract
Background: Osteoporosis is a global high prevalence of chronic metabolic disease with serious disability-adjusted
life years losing. Acupuncture is used to treat osteoporosis broadly in China and other countries although the
evidence on effectiveness cannot give a certain answer. The aim of this systematic review protocol is to appraise
the efficacy and safety of acupuncture for osteoporosis.
Methods: A literature search of randomized controlled trials focusing on acupuncture for osteoporosis will be
performed in the databases of Medline, Cochrane Library, Web of Science, EBASE, Springer, WHO International
Clinical Trials Registry Platform (ICTRP), China National Knowledge Infrastructure (CNKI), Wan fang, Chinese
Biomedical Literature Database (CBM), Chinese Scientific Journal Database (VIP), and other possible resources with
a valid search strategy. Outcomes of pain, bone mineral density, fracture, mortality, improvement proportion,
biochemical indicators, quality of life, adverse event, and other valid will be extracted and merged for quantitative
analysis using Review Manager software (V.5.3.5) or descriptive analysis correspondingly.
Discussion: This is the first systematic review to estimate the effect of acupuncture on osteoporosis, and the result
may provide evidence to clinical doctor.
Systematic review registration: PROSPERO CRD42016037829
Introduction
Description of the condition
Osteoporosis is a chronic metabolic disease character-
ized by mass loss, microstructure damage, brittleness
increases, strength decline, and fracture tendency of the
bone. Osteoporosis can attack different gender and age,
especially in postmenopausal woman and elderly male.
The prevalence of osteoporosis is in a worldwide growth,
such as 10.3 % in US older adults with 10.2 million
people [1], 13.0 % in China mainland at the population
of about 69.44 million [2, 3], and 6.6 and 22.1 % in men
and women aged 50 years or more, and 5.5 % in the
general population in the 27 countries of the European
Union with 27.5 million suffering osteoporosis [4].
Those numbers are increasing accompanying aging
population growth. Low back pain or systemic bone
pain, deformation of spinal column, and fragility fracture
are the main complaints of osteoporosis patient, which
markedly accelerate the illness burden, as well as the
personal and social financial expense. Based on the
burden disease of disability-adjusted life years (DALY),
osteoporosis fracture is ranked sixth, more than hyper-
tension [5]. DALY losses are also considerable in post-
menopausal osteoporosis [6]. The cost of incident and
prior fragility fractures is 37 billion Euros in the 27
countries of the European in 2010, and it will rise by
25 % in 2015 owing to the tendency of aging population
[4]. The aims of prevention and treatment of osteopor-
osis are to inhibit the rapid loss of bone mass, improve
the quality and strength of bone, relieve the pain, and
lower the risk of fracture, such as the basic therapy (e.g.,
combined calcium and vitamin D intake) and lifestyle
changes (restriction of tobacco and alcohol intake,
weight-bearing exercise, and avoidance of trip or fall
hazards) and drugs (e.g., bisphosphonate, calcitonin,
estrogen, parathyroid hormone, raloxifene, denosumab)
[7]. However, the drugs could bring about many un-
avoidable side effects such as increase of the risk of
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cardiovascular disease, gastrointestinal reaction, rhinitis
[7], and the basic therapy cannot effectively control the
incidence. Complementary and alternative therapy such
as acupuncture is applied more and more to treat osteo-
porosis [8, 9].
Description of the intervention
Acupuncture therapy, with a history of more than
2000 years in China and some Asian countries, is to pre-
vent and cure disease by the stimulation of specific acu-
point according to Chinese meridians and “Qi” theory.
There are different ways to stimulate the acupoint, such
as needling, electro-acupuncture, transcutaneous elec-
trical nerve stimulation (TENS), and moxibustion. Each
acupoint has its own specific therapeutic functions, and
the prescription of acupoint is formulated by different
acupoints and special stimuli ways basing on ancient
Chinese medicine theory [10].
How the intervention might work?
The effect mechanism of osteoporosis by acupuncture
has been not completely found so far. However, the
accumulated evidences have shown that acupuncture
could fortify bone strength by amending the mass,
mineral density, and structure in osteoporosis model
animal [11–14], which mainly activate the Wnt-β-
catenin signaling pathway to influence bone formation
and metabolism [15], as well as regulate the osteoproteg-
erin and receptor activator of nuclear factor-kB ligand
(RANKL) [16].
Why it is important to perform this review?
Osteoporosis is recognized as an aging and degenerative
condition caused by insufficiency of kidney qi in line with
theory of traditional Chinese medicine (TCM) in the an-
cient book of Inner Canon of Huangdi [17], and acupunc-
ture is widely applied to treat it from 2000 years ago as
well as herbs [18, 19]. In Australia, acupuncture is the
second most popular complementary and alternative
medicine after multivitamins for osteoporotic patient [20].
Nearly all TCM hospitals have employed acupuncture to
treat osteoporosis in Chinese. The improvement of bone
mineral density and analgesia are deemed to the potential
profit for osteoporosis [21]. Clinical research shows that
acupuncture is superior to Caltrate D in bone mineral
density enhancement of postmenopausal osteoporosis
[22]. Acupoint catgut embedding, a common kind of acu-
puncture, could increase the quality of life and adjust the
reproductive endocrine and bone metabolism of postmen-
opausal women [23]. Acupuncture plus standard combin-
ation therapy for secondary osteoporosis in patient with
spinal cord injury shows a better effect on the decreases of
immunoglobulin M (IgM) and tumor necrosis factor α
and the increase of bone mineral density in contrast with
standard combination therapy only [8]. Hence, the qualita-
tive and quantitative analysis of acupuncture for osteopor-
osis is vital.
Objectives
The aim of this study is to review the efficacy and safety
of acupuncture for osteoporosis.
Methods
Inclusive and exclusive criteria
Types of study
This review will be confined to randomized controlled trials
(RCTs) comparing acupuncture with a control group. If the
trial states the “randomization” phrase, it will be deemed a
randomized study, and the blinding will not be restricted.
The language will be limited as Chinese and English.
Types of participants
The participants of osteoporosis or osteopenia including
postmenopausal osteoporosis, secondary or primary
osteoporosis, and the fracture of different parts by osteo-
porosis will be included with no limitation of age, gender,
and ethnic origin. Osteoporosis should be diagnosed
clearly basing on bone mineral density with −2.5 < T score
<−1.0 or T score ≤−2.5 detected by imaging device [24].
Types of interventions
Different types of stimulation (e.g., manual acupuncture,
electro-acupuncture, transcutaneous electrical nerve
stimulation, magnets, laser, acupoint catgut embedding,
bleeding, acupoint injection, fire needle, needle knife,
superficial needling, acupressure, cupping jar, or moxibus-
tion) on specific points (e.g., traditional meridian points,
Ashi points, auricular points, abdominal acupuncture
points, and scalp acupuncture points) will be included.
The control interventions with drugs (conventional
pharmaceutical medicine, herbs or herb extracts, no
treatment or waiting list, placebo or sham, diet or phys-
ical activity therapy) will be included. Studies to com-
pare the effect of different kinds of acupuncture
stimulations or acupoints will be excluded. Besides, the
comprehensive treatments containing acupuncture will
be included if acupuncture could be tested by control
group, such as acupuncture plus control vs. control.
Types of outcome measures
Primary outcomes
1. Pain intensity
2. Bone mineral density
3. Global assessment of improvement proportion
4. Fracture
5. Mortality
6. Quality of life
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Secondary outcomes
1. Biochemical indicators related to osteoporosis such
as oestradiol (E2), serum calcium (Ca), phosphorus
(P),bone Gla protein (BGP), alkaline phosphatase
(ALP), calcitonin (CT), parathyroid hormone (PTH),
interleukin-6 (IL-6), and others.
2. Side effects caused by acupuncture.
Search methods for identification of studies
Electronic searches
A literature search will be conducted in the databases
of Medline, Cochrane Library, Web of Science,
EBASE, Springer, WHO International Clinical Trials
Registry Platform (ICTRP), China National Knowledge
Infrastructure (CNKI), Wanfang, Chinese Biomedical
Literature Database (CBM), Chinese Scientific Journal
Database (VIP) form the establishment to October,
2016.
Searching other resources
The other resources will be searched manually such as
the references of all included studies of this systematic
review and general review.
Search strategy
The search strategy will be formulated in accordance
with the guidance provided by the Cochrane Hand-
book. The Medline search strategy for title, abstract,
and Medical Subject Heading (MeSH) is listed as
Table 1, and others will be transformed basing on it.
Data collection and analysis
Selection of studies
All the studied presupposed criteria will be selected
and identified by the three authors (Taipin Guo, Xiao
Chen, and Bowen Zhu). With the identification of
title and abstract, the articles of duplicate and non-
clinical trial will be expurgated. And then the inten-
sive reading of full text could authenticate if some
papers are ambiguous in title or abstract. The papers
which do not meet the inclusion criteria will be ex-
cluded. Any disagreement should be resolved by dis-
cussion. The study of screening flow diagram is
summarized as Fig. 1.
Data extraction and management
The datum of each selected trial will be extracted and rec-
ord in a special electronic form. The candidate informa-
tion should be mainly composed of article general
information (e.g., article identification, authors, publica-
tion year), study methods (e.g., randomization, allocation
concealment, blinding, selective report, and other bias),
participants (e.g., inclusion and exclusion criteria,
demographic data like gender, age, duration of osteopor-
osis), details of invention in acupuncture and control
groups, duration of treatment, outcomes, follow-up, side
effect, and others. Two reviewers (Xiangnong Wu and
Exian Shan) will complete the extraction independently
and recheck crossly. Another reviewer (Yaju Jin) will liter-
ally inspect all the datum again. Bifurcations will be
judged by an arbiter after discussion (Taipin Guo).
Table 1 Medline search strategy for title, abstract and Mesh
Number Search terms
1 randomised controlled trial
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Assessment of risk of bias in included studies
The bias risk of the following seven domains will be ap-
praised by two reviewers (Xiantao Tai and Zili Liu) sep-
arately according to Cochrane handbook for systematic
reviews of interventions [25]: generation of random se-
quences, allocation concealment, blinding, incomplete
outcome data, selective reporting, and other issues. The
items of low risk of bias, high risk of bias, or unclear risk
of bias will be assigned to each issue. The Grading
of Recommendations Assessment, Development and
Evaluation (GRADE) will be used to evaluate the quality of
each trial. The divergence will be resolved by discussion.
Measures of treatment effect
Dichotomous data will be presented as risk ratio (RR)
and 95 % confidence intervals (CI), while continuous
outcomes will be showed as standard mean difference
(SMD) 95 % CI.
Unit of analysis issues
In order to avoid the unit of analysis error for multiple
treatment groups in a trial, we will apply the approaches
accordingly as follows: (1) separately reporting a pair
wise comparison with more than one control group, (2)
presenting subgroups of intervention result if there are
two or more different stimuli kinds of acupuncture
intervention groups, and (3) selecting and presenting the
optimal group if there are two or more different acu-
point prescription kinds of acupuncture intervention
groups.
Dealing with missing data
Referring to the Cochrane handbook for systematic
reviews of intervention [25], we will try to contact the
authors by telephone, email, or post to original investiga-
tors to request the missing data. If the missing data were
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animal mechanism (n= )
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with full text identified (n= )
Articles included  for data 
synthesis (n= )
Articles included  for
meta-analysis(n= )
Fig. 1 Flow diagram of studies identified
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when it is assumed to be missing at random; otherwise,
it will be imputed as the missing data with replacement
values.
Assessment of heterogeneity
The heterogeneity of the data will be calculated with χ2
test, and the values of I2 will be presented as the degree
of heterogeneity. An interpretation of I2 is as follows: (1)
0 to 40 %: might not be important; (2) 30 to 60 %: may
represent moderate heterogeneity; (3) 50 to 90 %: may
represent substantial heterogeneity; and (4) 75 to 100 %:
considerable heterogeneity.
Assessment of reporting biases
The symmetry of funnel plots will be used to detect the
reporting biases if more than 10 studies are included for
meta-analysis.
Data synthesis
All the primary and secondary outcomes will be merged,
and meta-analysis using Cochrane Collaboration Review
Manager software (RevMan V.5.3.5) will be performed.
According to Cochrane Handbook for Systematic Reviews
of Interventions, the fixed-effect model is used if the re-
sult may be viewed as a “typical intervention effect” from
the studies included in the analysis, and the random-
effects model is applied when the heterogeneity cannot
readily be explained.
As some trails only report the outcomes as pre- and post-
treatment values in intervention or control group, the mean
change will be obtained by subtracting pre- from post-
measurements. Meanwhile, the standard deviation (s.d.) for
changes will be calculated using the following formula:
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
s:d:2preþ s:d:2post−2 rpre; post s:d:pre s:d:postp ;
and the correlation coefficient (rpre, post) should be 0.5 [26].
Besides, the qualitative description will be implemented
when the result is not fit to quantitative analysis.
Subgroup analysis
We will conduct a subgroup analysis according to different
types of stimulation (e.g., manual acupuncture, electro-
acupuncture), such as subgroup 1 is manual acupuncture
vs. drug, and subgroup 2 is electro-acupuncture vs. drug,
and then to merge the subgroup results.
Sensitivity analysis
According to the integrated results of heterogeneity and
meta-analysis both in fixed-effect model and random-
effects model, the sensitivity analysis will be carried out
if there are great differences among the trials.
Ethics and dissemination
This systematic review will not require data for individ-
ual patient and it does not relate to privacy issues. The
results will be only disseminated on peer-reviewed publi-
cations and conference presentations.
Discussion
Osteoporosis is a global prevalence disease, and it led to
a great burden. There have no direct and efficient ap-
proaches to prevent and treat it by now. Acupuncture
has been widely used to treat osteoporosis in China
though lack of sufficient evidence. There has not any
systematic review that has been reported by now. To
synthesize the existing trials is vital, which could provide
a new strong proof of the effectiveness and safety for cli-
nicians, researchers, and health policy-makers.
The primary aim of this study is to test the effect of
acupoint for osteoporosis. So, the different types of
stimulation will be included either penetration of the
skin or not. Meanwhile, different kinds of osteoporosis
such as postmenopausal, senior, fracture will be incorpo-
rated. To explore and explain heterogeneity, subgroup
analysis will be applied basing on the different kinds of
acupuncture stimulation. This is the first time to do a
systematic review about acupuncture for osteoporosis,
and other outcomes reported in the original trials which
may be omitted in this protocol will probably be in-
cluded in the future.
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